What is Eye Tech Care?
Eye Tech Care is at the forefront of developing non-invasive solutions for glaucoma patients, leveraging advanced focused ultrasound technology. Their proprietary method offers a rapid and consistently repeatable treatment option for managing this widespread condition, which impacts millions globally. The company's mission is to revolutionize glaucoma patient care by providing effective alternatives to conventional surgical interventions, targeting healthcare providers and individuals seeking cutting-edge therapeutic options.
How much funding has Eye Tech Care raised?
Eye Tech Care has raised a total of $27.2M across 1 funding round:
Private Equity
$27.2M
Private Equity (2016): $27.2M with participation from EVERPINE Capital
Key Investors in Eye Tech Care
EVERPINE Capital
EVERPINE Capital is a private equity firm known for its focus on cross-border mergers and acquisitions, aiming to enhance the growth potential of its portfolio companies.
What's next for Eye Tech Care?
With substantial enterprise-level backing, Eye Tech Care is poised for significant growth and market expansion. The strategic investment suggests a focus on clinical validation, regulatory approvals, and broader commercialization of their non-invasive glaucoma treatment. Future developments will likely involve scaling manufacturing, building out sales and distribution channels, and potentially exploring new therapeutic applications for their focused ultrasound technology. The company's trajectory points towards becoming a key player in the ophthalmology sector.
See full Eye Tech Care company page
